PharmaCyte Biotech, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Las Vegas, NV
SEC filing record 1 source field available
Fiscal year end
30 April
PharmaCyte Biotech, Inc. has filed 469 SEC EDGAR filings since 20 Aug 2001

SEC filing history

Showing 51-75 of 389 matching filings.

Per page
25
Current page
3
SCHEDULE 13G/A File 005-91495

SCHEDULE 13G/A filing

Filing date
15 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40699

FORM 10-Q FOR OCTOBER 2024

Filing date
13 Dec 2024
Reporting date
31 Oct 2024
Next action
Verify source filing
S-8 File 333-283613

REGISTRATION STATEMENT

Filing date
04 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91495

AMENDMENT NO. 4 TO SCHEDULE 13G

Filing date
13 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40699

FORM 10-Q FOR JULY 2024

Filing date
17 Sep 2024
Reporting date
31 Jul 2024
Next action
Verify source filing
NT 10-Q File 001-40699

EXTENSION

Filing date
17 Sep 2024
Reporting date
31 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-40699

FORM 10-K FOR APRIL 2024

Filing date
13 Aug 2024
Reporting date
30 Apr 2024
Next action
Verify source filing
NT 10-K File 001-40699

FORM 12B-25

Filing date
29 Jul 2024
Reporting date
30 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jul 2024
Reporting date
30 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jul 2024
Reporting date
30 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jul 2024
Reporting date
30 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jul 2024
Reporting date
30 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-36268

3 filing

Filing date
30 May 2024
Reporting date
23 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D

SCHEDULE 13D

Filing date
30 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40699

DEFINITIVE PROXY STATEMENT

Filing date
27 Mar 2024
Reporting date
29 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-40699

ANNUAL REPORT

Filing date
27 Mar 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40699

FORM 10-Q FOR JAN 2024

Filing date
18 Mar 2024
Reporting date
31 Jan 2024
Next action
Verify source filing
SC 13G File 005-91495

SC 13G filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91495

AMENDMENT NO. 3 TO SCHEDULE 13G

Filing date
06 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40699

FORM 10-Q FOR OCTOBER 2023

Filing date
15 Dec 2023
Reporting date
31 Oct 2023
Next action
Verify source filing
3 File 001-40492

3 filing

Filing date
28 Nov 2023
Reporting date
21 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2023
Reporting date
20 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .